CD4 and pneumocystosis: HIV-infected populations who have remained at risk of PCP in the post-anti-retroviral therapy (ART) era include individuals who are undiagnosed, do not have access to ART, are unable to tolerate ART, in whom ART is not effective, and those with CD4+ T cell counts less than 200 cells/ul (5).